Search

Filters

Clear Filters
3:15 PM - 3:20 PM ET

1062 - Interpretable Artificial Intelligence Decision Support Framework for Online Adaptive Radiotherapy Quality Assurance
Speaker: Winter, Jeff, PhD - Princess Margaret Cancer Centre, Toronto, Ontario
3:20 PM - 3:25 PM ET

1063 - From Feasibility to Clinical Practice: Direct-to-Treatment Ultra-Hypofractionated Whole-Breast ART with AI-Based Segmentation
Speaker: Parsons, David, PhD - University of Texas Southwestern Medical Center, Dallas, TX
3:25 PM - 3:30 PM ET

1064 - Assessment of Image Guidance and Adaptive Planning on the ART of SABR Phase II Trial for Near "Margin-Less" Adaptive Radiation Therapy of Primary Localized Prostate Cancer
Speaker: Morris, Toby - Mayo Clinic, Scottsdale, AZ
3:30 PM - 3:35 PM ET

1065 - Universal Zero-Shot Contour Propagation via Prior-Guided Learning for Adaptive Radiotherapy
Speaker: Lyu, Zeyang - Fudan University Shanghai Cancer Center, Shanghai, DC
5:20 PM - 5:25 PM ET

1066 - Rb1-S780 Phosphorylation as a Potential Biomarker for Grade 1.5 Meningiomas and Adjuvant Radiotherapy Decision Making
Speaker: Guzel, Caglar, MD - Erzurum City Hospital, Erzurum, Erzurum
5:25 PM - 5:30 PM ET

1067 - Association of SMARCA4 Primary Tumor Mutations with Brain Metastases in Initially Non-Metastatic Non-Small Cell Lung Cancer
Speaker: Ellendula, Maneeth, BS - Yale School of Medicine, New Haven, CT
5:30 PM - 5:35 PM ET

1068 - Mutational Gene Signature Defines a High-Risk Subtype of Lung Adenocarcinoma with Genomic Instability and High Propensity for Brain Metastasis
Speaker: Zhang, Chuanbao - Stanford University, Palo Alto, CA
5:35 PM - 5:40 PM ET

1069 - SETD2 Loss Enhances Radiosensitivity and Predicts Improved Survival in High-Grade Gliomas
Speaker: Suh, Won Young - Department of Radiation Oncology, Seoul National University College of Medicine, Seoul
3:20 PM - 3:30 PM ET

107 - Co-Primary Endpoint Analysis for the INTREPId Randomized Trial of Prostate Radiation Therapy with Androgen Deprivation Therapy vs. Darolutamide Monotherapy
Speaker: King, Martin, MD, PhD - Brigham and Women's Hopsital, Boston, MA
5:40 PM - 5:45 PM ET

1070 - PI3K and ATM Alterations Drive Distinct Intracranial Recurrence Patterns after Melanoma Brain Metastasis Resection
Speaker: Lee, James - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
5:45 PM - 5:50 PM ET

1071 - BrAIn_Path: A Novel Deep Learning Histopathology Score for Prognostication and Risk Stratification In Resected Brain Metastases
Speaker: Yazdani, Zachariya - Memorial Sloan Kettering Cancer Center, New York, NY
3:05 PM - 3:10 PM ET

1072 - Patient prior Personalization Enables Robust CTV Auto-Contouring for Online Adaptive Radiotherapy in Cervical Cancer
Speaker: Wang, Guangyu, MD - Peking Union Medical College Hospital, Beijing, Beijing